Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Enzo Biochem Inc.
ENZ
$
2.85
-3.4%
Tue January 5th, 2021
18:27
Press Releases
Roumell Announces Preliminary Annual Meeting Results for Enzo Biochem, Inc.
PR Newswire
Thu December 31st, 2020
18:46
Press Releases
Leading Proxy Advisory Firms, Institutional Shareholder Services and Glass Lewis, Recommend That Shareholders Vote AGAINST Elazar Rabbani at Enzo's Upcoming Annual Meeting
PR Newswire
Thu December 24th, 2020
19:06
Press Releases
Roumell Asset Management Files Definitive Proxy Statement and Sends Letter to Enzo Biochem Shareholders
PR Newswire
Wed December 16th, 2020
05:42
Analysis
Enzo Biochem: Betting On The Activists Now
Seeking Alpha
Thu December 10th, 2020
05:14
Earnings
Analysis
Enzo Biochem, Inc. (ENZ) Q1 2021 Results - Earnings Call Transcript
Seeking Alpha
Wed October 14th, 2020
11:53
Digest
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
Benzinga
00:59
Earnings
Analysis
Enzo Biochem, Inc.'s (ENZ) on Q4 2020 Results - Earnings Call Transcript
Seeking Alpha
Tue September 15th, 2020
13:45
Analysis
Enzo Biochem, Inc: Wildly Undervalued COVID-19 Test Play With Near-Term Catalysts
Seeking Alpha
Tue June 9th, 2020
17:59
Analysis
Enzo Biochem (ENZ) Investor Presentation - Slideshow
Seeking Alpha
00:16
Earnings
Analysis
Enzo Biochem, Inc. (ENZ) Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
